Patent · US Active

Anti-cancer/anti-fibrosis compounds

US11932606B2 · kind B2 · utility

0Cited by
3References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 2018
Grant dateMar 19, 2024
Priority date
Expiry dateMar 9, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides, among other things, compounds useful for treating diseases such as fibrosis and/or cancer, pharmaceutical formulations containing such compounds, as well as combinations of these compounds with at least one additional therapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.